Since 2009, there have been lots of changes being implemented at the FDA. Understanding FDA’s strategic priorities for 2014 and beyond can help prioritize business goals and objectives concerning regulatory plan/strategy, product approvals and clearances and FDA registration and listing.
Based on new laws, statutes and new regulations, US FDA is implementing the statutory requirements. It is imperative that the healthcare industry understand what regulatory requirements may be relevant and applicable to firms affected.
Join Dr. David Lim, Ph.D., RAC, ASQ-CQA in this audio session to learn and understand the applicable regulatory requirements so that implementation of necessary regulatory requirements, if applicable, can be planned early and carried out in an effective and sustainable manner.
In this 60 minute session, David will share US FDA’s strategic priorities – 2014 and beyond.
Areas To Be Covered in this Session:
Who should attend
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). As a leading industry speaker, Dr. Lim frequently presents various topics in areas of FDA regulatory, clinical, quality and regulatory compliance matters in various forums and meetings.